Table 1.
ILC type | Sources of activation | Transcription factor | Subtypes | Effector molecules | Role in disease |
---|---|---|---|---|---|
ILC-1 | IL-12 IL-15 IL-18 |
T-bet | Conventional NK cells CD103+ intraepithelial ILC (ieILC-1) CD127+ |
IFN-γ NK and ieILC-1: Granzyme Perforin |
Immune response against intracellular pathogens and tumors Chronic gastrointestinal and pulmonary inflammation |
ILC-2 | IL-25 IL-33 TSLP |
GATA3 | Amphiregulin IL-4 IL-5 IL-9 IL-13 |
Immune response against helminths Driver of allergic disease and asthma |
|
ILC-3 | Aryl hydrocarbon receptor ligand IL-1 IL-6 IL-23 |
RORγt | Lymphoid tissue-inducer (LTi) NKp44+ T-bet + RORγt + double positive |
IL-17 IL-22 LTi: LT-β TNF-α T-bet/RORγt+: IFN-γ |
Immune response against extracellular pathogens Disease of gut and skin barrier, including inflammatory bowel disease and psoriasis |
IFN interferon, IL interleukin, ILC innate lymphoid cell, LT-β lymphotoxin β, LTi lymphoid tissue-inducer, TNF-α tumor necrosis factor α, TSLP thymic stromal lymphopoietin